30
Participants
Start Date
December 7, 2016
Primary Completion Date
October 20, 2017
Study Completion Date
October 20, 2017
Abicipar pegol
Abicipar pegol 2 mg administered to the study eye by intravitreal injection.
Caroline Eye Associates, Southern Pines
Retina Specialty Institute, Pensacola
University of Miami, Coral Gables
The Eye Institute of West Florida, Largo
Center for Retina and Macular Disease, Winter Haven
East Florida Eye Insititute, Stuart
Cole Eye Institute, Cleveland Clinic, Cleveland
Raj K. Maturi, MD, Indianapolis
Davis Duehr Dean, Madison
Rocky Mountain Retina Consultants, Salt Lake City
Retinal Consultants of Arizona, Gilbert
Retina Vitreous Associates Medical Group, Beverly Hills
Win Retina, Arcadia
California Eye Specialists Medical Group, Inc-Private Clinic, Pasadena
Jacobs Retina Center, Shiley Eye Institute, UCSD, La Jolla
Atlantis Retina Institute (Atlantis Eyecare), Huntington Beach
Massachusetts Eye & Ear, Boston
Eyesight Ophthalmic Services, PA, Portsmouth
Lead Sponsor
Allergan
INDUSTRY